Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Chunmeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6622-3958; OpenAlex author ID A5001537046. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 5

  1. Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Co-author DOI 10.1245/s10434-026-19841-5↗
  2. ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-anal… Co-author DOI 10.1245/s10434-026-19926-1↗
  3. An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2021.12.018↗
  4. Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2022.215922↗
  5. Geographic variation in attitudes regarding management of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.sopen.2022.07.007↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bradley Norman Reames · 4 shared papers, 2022–2026 · strength 0.82
  2. José Oberholzer · 2 shared papers, 2026 · strength 0.50
  3. Ning Pu · 2 shared papers, 2026 · strength 0.50
  4. Haleh Amirian · 2 shared papers, 2026 · strength 0.50
  5. Dilmurodjon Eshmuminov · 2 shared papers, 2026 · strength 0.50
  6. Víctor López‐López · 2 shared papers, 2026 · strength 0.50
  7. Michael C. Frey · 2 shared papers, 2026 · strength 0.50
  8. So Heun Lee · 2 shared papers, 2026 · strength 0.50
  9. Ralph Fritsch · 2 shared papers, 2026 · strength 0.50
  10. Changhoon Yoo · 2 shared papers, 2026 · strength 0.50
  11. Jashodeep Datta · 2 shared papers, 2026 · strength 0.50
  12. Lynette M. Smith · 2 shared papers, 2022 · strength 0.31
  13. Chi H. Lin · 1 shared paper, 2022 · strength 0.19
  14. Michael J. Baine · 1 shared paper, 2022 · strength 0.19
  15. Logan R. McNeil · 1 shared paper, 2022 · strength 0.13
  16. Chandrakanth Are · 1 shared paper, 2022 · strength 0.13
  17. Jin Peng He · 1 shared paper, 2022 · strength 0.13
  18. Georgios Gemenetzis · 1 shared paper, 2022 · strength 0.13
  19. Robert W. Krell · 1 shared paper, 2022 · strength 0.13
  20. Christopher Lee Wolfgang · 1 shared paper, 2022 · strength 0.13
  21. Matthew John Weiss · 1 shared paper, 2022 · strength 0.13
  22. Massimo Falconi · 1 shared paper, 2022 · strength 0.13
  23. Vincent P. Groot · 1 shared paper, 2022 · strength 0.13
  24. Aslam M. Ejaz · 1 shared paper, 2022 · strength 0.13
  25. Alex B. Blair · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.